IntelGenX
About
IntelGenX is an oral drug delivery company primarily that focuses on the development and manufacturing of pharmaceutical oral films.
- Saint Laurent,Quebec,Canada
- 11 - 50
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $3M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2003
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Stock Symbol
- otcqx:IGXT
- Legal Name
- IntelGenX Corp.
- Also Known As
- IntelGenx Technologies Corp.,Big Flash Corp.
IntelGenx is an oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform. It provides comprehensive pharmaceutical services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP, and regulatory services. IntelGenx’s state-of-the-art manufacturing facility, established for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, offering full-service capabilities to its clients.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 9, 2023 | Post-IPO Debt | $3M | 1 |
ATAI Life Sciences
|
— | Detail |
| Feb 1, 2022 | Post-IPO Debt | $3M | 1 |
ATAI Life Sciences
|
— | Detail |
| Mar 15, 2021 | Post-IPO Equity | $12.34M | 1 |
ATAI Life Sciences
|
— | Detail |
| Mar 15, 2021 | Post-IPO Debt | $2M | 1 |
ATAI Life Sciences
|
— | Detail |
| May 8, 2018 | Post-IPO Equity | $3.20M | — | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
ATAI Life Sciences
|
Yes | Post-IPO Debt |
Employee Profiles
